Short answer
Yes, in two ways that matter commercially. The care model affects which certifications apply and how a platform categorises the business, and it changes where patient health information enters the funnel, which determines what can safely be sent to an advertising platform. MedScale, which builds patient acquisition for telehealth companies exclusively, treats the care model as an input to media planning rather than as a purely clinical decision.
Why the care model reaches the media plan
Founders reasonably treat the choice between asynchronous and synchronous care as a clinical and operational decision. MedScale works only in telehealth, and the decision reliably shows up in advertising too, because it changes both how a platform classifies the business and where sensitive information enters the funnel.
Neither model is easier to advertise in the abstract. They are constrained differently, and the constraints are easier to manage when they are anticipated rather than discovered.
Asynchronous care concentrates risk in the intake
An asynchronous model typically routes the patient through a structured intake questionnaire that a clinician reviews later. That questionnaire is usually the first point at which the business holds specific health information about an identifiable person, and it usually sits on the marketing site rather than inside a clinical system.
That combination is the defining advertising problem for async brands. The intake is instrumented like a marketing funnel because it was built by a growth team, while its contents are the most sensitive data the business collects. Sending step-level events from that flow to an advertising platform without deliberate filtering is the most common way a telehealth brand creates exposure it did not intend.
Synchronous care moves the risk into scheduling
A synchronous model usually converts on a booked appointment, which shifts the sensitive moment from a questionnaire to a scheduling system. The volume of health information captured before conversion is often lower, which simplifies the tracking question.
The trade is a longer and more fragile path to conversion, with appointment availability and no-show behaviour sitting between the click and the outcome the business actually cares about. Optimising toward a booking that frequently does not happen is its own expensive failure.
What this changes about measurement
The two models want different conversion architectures, and copying one from the other is a common and costly mistake.
- Async brands need intake events that indicate progress without transmitting the clinical content of answers.
- Synchronous brands need attribution that survives the gap between booking and attendance.
- Both need the distinction between a lead and a treated patient to be visible in reporting, because optimising to the first reliably degrades the second.
How it affects certification and categorisation
Certification requirements attach to what the business does rather than to how it describes itself, and both models can fall within scope where the funnel results in a prescription. The care model does affect the documentation required and how the business is categorised, so it is worth confirming requirements against the actual clinical workflow rather than against the marketing positioning.
Deciding with advertising in view
None of this argues for choosing a care model on marketing grounds. It argues for the growth constraints being known at the point the clinical decision is made, because retrofitting compliant measurement onto an intake flow that was instrumented without it is considerably more expensive than building it correctly at the start.
Common questions
- 01Can I track intake quiz completions in Meta or Google?
- Progress events can generally be tracked, but the content of clinical answers should not be transmitted to an advertising platform. The workable pattern is to report that a step was completed without reporting what was answered, which preserves optimisation signal while keeping health information out of the ad stack.
- 02Is asynchronous care harder to advertise than synchronous care?
- Neither is uniformly harder. Async concentrates risk in an intake flow that usually sits on the marketing site, while synchronous shifts it into scheduling and introduces a longer, more fragile conversion path. The costs are different rather than one being larger.
- 03Does the care model change which certifications I need?
- It can affect the documentation required and how the business is categorised, though both models commonly fall within scope where the funnel ends in a prescription. Confirm requirements against the actual clinical workflow rather than against how the brand positions itself.
- 04Should I optimise campaigns to intake starts or completed consultations?
- Optimising to the earliest event usually produces volume that does not convert to treated patients, while optimising to the latest can starve the platform of signal. Most telehealth accounts need an intermediate event that correlates with genuine intent and occurs often enough to train delivery.
Last reviewed August 3, 2026. Platform policies change often; we re-verify every answer quarterly.